Skip to main content
Home
Browse by Topic
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Web Exclusives
Special Series
Conference Correspondent
ASH 2023 - CLL
Ovarian Cancer Overview
Multimedia
All Videos
Interview with the Innovators
Quick Quiz
Subscribe
Home
Browse by Topic
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Web Exclusives
Special Series
Conference Correspondent
ASH 2023 - CLL
Ovarian Cancer Overview
Multimedia
All Videos
Interview with the Innovators
Quick Quiz
Subscribe
How Real-World Data Are Consolidating Our Knowledge Regarding Melanoma Treatment
Video
,
ASCO Highlights
Videos
Sanjiv Agarwala, MD
Dr Sanjiv Agarwala reviews real-world data presented at ASCO 2018 on immunotherapy of melanoma that serve to reassure providers regarding current treatment approaches, but do not offer any significant practice-changing results.
Related Items
Dostarlimab Elicits 100% Complete Response Rate in Cohort of Patients with dMMR Rectal Cancer
By
Patricia Stewart
TOP - July 2022 Vol 15, No 4
Rectal Cancer
,
ASCO Highlights
Ibrutinib Added to Standard-of-Care Therapy Improves Progression-Free Survival in Older Patients with MCL
By
William King
TOP - July 2022 Vol 15, No 4
ASCO Highlights
Acalabrutinib Shows Promise in Patients with MZL
By
Patricia Stewart
TOP - July 2022 Vol 15, No 4
ASCO Highlights
Trastuzumab Deruxtecan Shows Survival Benefit in HER2-Positive Advanced Gastric Cancers
By
William King
TOP - May 2022 Vol 15, No 3
ASCO Highlights